Neuromarketing Ethics in Emerging Markets:
Privacy, Autonomy, and the Regulatory Vacuum in Pakistan
Keywords:
Ethics in Neuromarketing; Neural Data; Consumer Privacy; Informed Consent; Autonomy; Data Protection; Institutional Voids; Pakistan. JEL Classification: M31, M38, K24, O33Abstract
Neuromarketing tools such as electroencephalography (EEG), eye tracking, facial coding and galvanic skin response capture signals that consumers cannot consciously filter, raising serious concerns about privacy, informed consent and autonomy. This paper examines these risks in Pakistan and assesses whether Pakistani law is equipped to govern them. The study combines an integrative review of the neuromarketing ethics and neurorights literature, a doctrinal analysis of Pakistani legal instruments against ten safeguards derived from international standards (including the EU General Data Protection Regulation, the EU Artificial Intelligence Act, Chilean neurorights jurisprudence and the 2025 UNESCO Recommendation on the Ethics of Neurotechnology), and a secondary analysis of reconciled results from a doctoral survey of 1,152 marketing professionals in Karachi. None of the ten safeguards is fully provided by Pakistani law in force: six are absent and four are only partly covered by general provisions. Meanwhile, professionals show strong readiness to adopt neuromarketing (mean intention 3.92 on a five point scale), driven by organisational resources (β = 0.266) rather than professional norms (β = 0.008, not significant). Adoption is therefore advancing faster than governance; a condition we characterise as an institutional void. The paper constitutes the first regulatory gap analysis of neuromarketing in Pakistan, consolidates principlism, contextual integrity, institutional theory and Islamic business ethics into a novel conceptual framework, derives five testable propositions, and recommends a phased policy roadmap prioritizing on the recognition of neural data as sensitive data, explicit consent, measures for the protection of children, and ethics review of commercial studies.



